Merz Therapeutics and Kvvit Enter Exclusive Agreement for INBRIJA® (levodopa inhalation powder) in Mainland China, Hong Kong and Macao

    Merz Therapeutics and Kvvit Enter Exclusive Agreement for INBRIJA® (levodopa inhalation powder) in Mainland China, Hong Kong and Macao

    Kvvit to lead local development, regulatory activities and commercialization of INBRIJA® in mainland China, Hong Kong and Macao​ Under the agreement, Merz Therapeutics will receive upfront, development and commercial milestone payments, and tiered supply and royalty arrangements, with no manufacturing rights granted to Kvvit​ FRANKFURT, Germany & GANZHOU, China, May 26, 2026–(BUSINESS WIRE)–Merz Therapeutics GmbH…

    Read More
    Opinion | Where US jealously guards tech, China offers a collaborative ecosystem

    Opinion | Where US jealously guards tech, China offers a collaborative ecosystem

    Windsurf was a rising artificial intelligence (AI) start-up – until it wasn’t. Days after OpenAI’s US$3 billion acquisition deal collapsed, Windsurf’s founders and top researchers joined Google DeepMind under a non-exclusive licensing agreement. What remained was sold to another company. Windsurf, as an independent innovator, ceased to exist. This is how many AI start-ups today…

    Read More